Exscientia | Results Presentation Deck | 19 slides

Exscientia · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

19
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
The slide uses a dual-track timeline approach (Pipeline vs Platform/Corporate) for 1H 2023, followed by a list for 2H 2023.summarize
Open slide detailBeat · Attention
04
present_framework
Open slide detailBeat · Attention
05
The diagram represents a closed-loop iterative process for drug discovery.present_framework
Open slide detailBeat · Need
06
The slide uses a cyclical process flow to represent an adaptive clinical trial framework.present_solution
Open slide detailBeat · Need
07
The slide uses a visual list of protein structures to represent drug candidates.present_solution
Open slide detailBeat · Need
08
summarize
Open slide detailBeat · Need
09
transition
Open slide detailBeat · Satisfaction
10
The chart uses a horizontal bar format to represent development stages. One bar is orange (EXS4318), while the others are teal.present_solution
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
11
transition
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
12
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).plan_implementation
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
13
The slide uses a human anatomy diagram to map specific cancer types to their respective locations in the body.size_opportunity
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
14
The waterfall plot shows sensitivity vs resistance; the right side shows pathway analysis and combination testing strategy.analyze_data
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
15
The slide uses a combination of a bar chart for single-agent sensitivity and a heatmap for combination synergy results.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
16
The Venn diagram illustrates the overlap of genes modulated by '617 in peripheral blood vs primary tumours, highlighting the potential for non-invasive biomarkepresent_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
17
The slide highlights financial stability despite fluctuations in cash inflows from collaborations.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
18
The slide uses a dual-track timeline (Pipeline Progress vs Platform and Corporate Advancements) for 1H23, followed by a list for 2H23.summarize
Open slide detailBeat · Action
19
appendix
Open slide detailBeat · Action